Bone Morphogenetic Protein 7 Is Expressed in Prostate Cancer Metastases and Its Effects on Prostate Tumor Cells Depend on Cell Phenotype and the Tumor Microenvironment

by Colm Morrissey, Lisha G. Brown, Tiffany E.M. Pitts, Robert L. Vessella, Eva Corey
Published 2010-02-01

Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone

by Eva Corey, Robert L. Vessella, Linda A. Snyder, Holly M. Nguyen, Lisha G. Brown, Theodore Koreckij, Peter S. Kirk
Published 2013-05-01

Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature.

by Mark P Labrecque, Lisha G Brown, Ilsa M Coleman, Holly M Nguyen, Daniel W Lin, Eva Corey, Peter S Nelson, Colm Morrissey
Published 2021-01-01

Inhibition of Androgen-Independent Prostate Cancer by Estrogenic Compounds Is Associated with Increased Expression of Immune-Related Genes

by Ilsa M. Coleman, Jeffrey A. Kiefer, Lisha G. Brown, Tiffany E. Pitts, Peter S. Nelson, Kristen D. Brubaker, Robert L. Vessella, Eva Corey
Published 2006-10-01

Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling.

by Holly M Nguyen, Nazanin Ruppender, Xiaotun Zhang, Lisha G Brown, Ted S Gross, Colm Morrissey, Roman Gulati, Robert L Vessella, Frauke Schimmoller, Dana T Aftab, Eva Corey
Published 2013-01-01